Reliance Capital - Initiating Coverage - Centrum 06122012
Reliance Capital - Initiating Coverage - Centrum 06122012
Reliance Capital
Initiating Coverage 06 December 2012
Key Data
Bloomberg Code RCAPT IN RLCP.BO 245.6 245.6 111.3/2.1 476/223 3,559,125 10 Outperform Outperform
Buy
Target Price: Rs585 CMP: Rs436 Upside: 29%
*as on 06 December 2012
Difficult business environment for equity linked Reuters Code businesses; sweeping regulatory changes in insurance (life & non-life) and a generally weak macro have led to Current Shares O/S (mn) significant erosion in return ratios of RCAP. However, Diluted Shares O/S(mn) the tide is gradually turning as individual business Mkt Cap (Rsbn/USDbn) segments overcome sector specific challenges and macro is on the mend leading to improved outlook for 52 Wk H / L (Rs) capital market linked businesses. Current market price Daily Vol. (3M NSE Avg.) disregards long term value seen by strategic investors Face Value (Rs) and under-appreciates a potent banking platform in 1 USD = Rs54.1 making. We initiate coverage with a Strong Buy Stock to Sector recommendation with an upside of ~30%.
Life insurance business: restructuring underway: RLIFE has undertaken restructuring of its business model after dramatic regulatory changes in 2010 with strong focus on profitability vs growth earlier. Shifted product mix, shedding of inactive agents, incremental focus on Tier I locations and potential bancassurance tie-up should drive productivity gains and hence improvement in profitability. Capital market business: better times ahead: A dominant market share (12%), gradually improving sentiments towards equity and better participation from retail investors brightens the medium term prospects of the asset management business. In addition, the 25 bps hike in expense ratio and leeway to recover service tax on expenses should allow asset management companies to increase commissions and in turn improve AUM inflows especially so for large funds such as RCAM. Gen. insurance business on brink of profitability: Dismantling of commercial third-party motor pool and anticipated firmness in insurance tariffs are expected to turn the fortunes of general insurance businesses. Effectively, the combined ratio (current industry average at ~120%) is expected to improve going forward. We expect RGEN to turn profitable in FY14 led by 1) absence of third party motor pool contribution in FY14 2) diversification of product mix and 3) gradual hike in tariff rates as PSU insurers aim profitability. Lending business gaining traction: Preference towards secured credit and niche focus on self-employed borrowers has endowed RCF with a healthy NIM and a strong hold on credit quality. We expect NIMs to improve going forward led by lower wholesale cost of funds (~50% of borrowings), which along with contained credit costs should drive expansion in return ratios even as loan book growth remains moderate (~15% YoY). Initiate coverage with Buy: Improving macro context and easing in business specific headwinds should drive expansion in return ratios for RCAP. In addition, unwinding of non-core investment to reduce debt should further improve profitability profile. At CMP, the stock is trading at a steep discount to its fair value of Rs585. We initiate coverage with a Buy rating.
Sector to Market
Shareholding Pattern
Others 19% DII 6%
Promoter 54%
FII 21%
As on 30 September 2012
RELIANCE CAPITAL
Company Background
Reliance Capital Ltd is one of the largest financial services company in India in terms of net worth and offers multitude of services ranging from consumer finance to mutual funds, insurance (life & general) to asset reconstruction, stock broking to depository services. The company operates in all these sectors through the medium of subsidiaries namely Reliance Mutual Fund, Reliance Life Insurance, Reliance General Insurance, and Reliance Money. Recently the company made its foray into the upcoming consumer finance field.
Organization structure
Core Businesses Asset Management Broking & distribution
Retail & Institutional Broking Distribution of Third Party Products
Life Insurance
Commercial Finance
General Insurance
Mutual Fund
Exchanges
Offshore Funds
Private Equity
Pension Funds
Wealth Management
Managed Accounts
Investment Banking
Asset Reconstruction
Venture Capital
Amit Bapna
CFO, RCAP
Amitabh Mohanty
K. V. Srinivasan
CEO, Reliance Commercial Finance CEO, Reliance Capital Asset Management CEO, Reliance General Insurance ED & President, Reliance Life Insurance Company
Sundeep Sikka
Rakesh Jain
Malay Ghosh
Vikrant Gugnani
He leads international business strategy across all lines of Reliance Capital businesses. A Chartered CEO, International Businesses Accountant by qualification, he has over 19 years of extensive experience in the financial industry and has worked in various countries with global firms like Citibank and S. B. Billimoria & Co CIO, RCAP He was heading the Equity Investments at Reliance MF for nearly 10 years. In his 20 years of experience, he has served at UBS, Peregrine Securities & Motilal Oswal Securities.
Madhusudan Kela
Private Insurers
0 FY05 FY06 FY07 Bajaj Allianz ICICI Pru Reliance Life Br FY08 FY09 FY10 Birla Sun Life Kotak Life SBI Life FY11 FY12 HDFC Life Max Life
Life insurance industry at inflection point: With a large part of regulatory overhang behind us, the life insurance industry has stabilized its operations and has adjusted its business model to the new operating environment. Given that, we believe the industry is at an infection point, structural positives (rising incomes, higher share of working population and increasingly sophisticated customer needs) should drive the next leg of growth. Increase in foreign direct investment (FDI) limit will only act as a catalyst to this second phase of the decisively promising journey ahead. Life insurance business: restructuring underway: In line with the industry, RLIFE has undertaken restructuring of its business model after dramatic regulatory changes in 2010 with strong focus on profitability vs growth earlier. Product mix has shifted away from ULIPs to traditional products. Though this has lowered profitability in near term it should augur well in medium to long term in the form of better persistency. Shedding of inactive agents, consolidation of branch network and incremental focus on Tier I and 2 locations (vs current focus on Tier 3 centres) to tap the big-ticket market should lead to productivity gains. Moreover, RLIFE is exploring bancassurance possibilities aggressively given the lucrative cost-benefit equation offered as well as the proposed changes to regulations governing bancassurance channel.
Product mix transition largely over: Given the regulatory changes, the life insurance industry has changed its product mix gradually in favor of traditional products. In line, RLIFE too has shifted away from ULIPs (forming 90% of premium at one point to 20% now). Focus on productivity: In addition to the change in product mix, RLIFE has adopted a multipronged approach to improve productivity and efficiency. For instance, the agency force continues to be trimmed as inactive agents are dropped. Also, RLIFE has not added new branches since FY2010 with a view to optimally utilize the existing infrastructure. A review of RLIFEs operating expense ratio indicates that there still exists significant scope for operating leverage. Exhibit 12: Reliance Life Insurance: agency force
250,000 200,000 150,000 100,000 50,000 0 Q1FY10 Q2FY10 Q3FY10 Q4FY10 Q1FY11 Q2FY11 Q3FY11 Q4FY11 Q1FY12 Q2FY12 Q3FY12 Q4FY12 Q1FY13
FY12
FY06
FY07
FY08
FY09
FY10
FY11
Incremental expansion in Tier I locations: So far, RLIFEs 1230 strong branch network is in Tier 2 and 3 centres focusing on the middle class. With fairly strong presence in Tier 2 & 3 centres, RLIFE now intends to expand in Tier 1 centres (Top 15 cities) given the strong demand for term insurance and big-ticket nature of opportunity. Expansion in Tier 1 centres should augur well for overall productivity of the operations. Bancassurance channel - a distinct possibility: One of the key differences between RLIFE and close rivals is RLIFEs strong dependency on agency channel due to the absence of bancassurance. Bancassurance has its obvious benefits such as: ready access to banks customer base, access to customers financial information, cost efficiency as there is no investment in physical infrastructure, repeat business due to customer loyalty. The absence of bancassurance channel has translated into lower persistency rates and higher commission and operating expense ratios for RLIFE. While most leading banks have promoted their own insurance companies (and hence no scope of tie-up), the remaining banks demand uneconomical terms (upfront payment + normal commission) rendering bancassurance channel unviable. However, IRDA has proposed new regulations governing bancassurance which is likely to open up bancassurance channel options for RLIFE. While such a development could be a little time away, addition of bancassurance to channel portfolio would be immensely beneficial for RLIFE from a profitability and productivity perspective.
Q2FY13
Positive equity outlook + dominant position: Domestically, equity asset class has performed well on CYTD basis with Sensex up ~27% as sentiment turned positive post announcement of reforms and drove in healthy FII inflows. Incremental reform announcements and anticipated revival in economic activity should keep the equity asset class in good stead. In turn, this should lead to improvement in participation from retail investors who have avoided equity asset class in recent years. RCAM with its dominant market share and wide distribution network would be a key beneficiary and hence we expect the declining trend in MF AUM to reverse in FY2013.
80% 60%
Debt
Expense Ratio Earlier Revised 2.50 2.25 2.00 1.75 3.03 2.76 2.48 2.21
Hike in expense ratio to improve profitability: Since the removal of entry load on mutual fund units, inflows into AUM pool have dropped sharply with aggressive distribution of mutual funds loosing steam. However, a hike of 25bps in expense ratio is being considered by the regulator with a view to revive the inflows into mutual funds. Currently, the expense ratio is capped due to the slab structure (refer to exhibit below). In addition, there is a proposal to recover service tax on the expense ratio from unit buyers, which currently is borne by mutual fund companies. A hike in expense ratio would allow asset management companies to offer higher commission to distributors which in turn would attract inflows. Importantly, since the expense ratio is the function of the total corpus, the benefit of the increase in expense ratio will be more for bigger fund houses than smaller ones. RCAM being a dominant player in asset management industry stands to gain substantially if the proposal gets accepted and implemented. Nippon allocation could be game changer: RCAP had sold a 26% stake in Reliance Mutual Fund to Nippon Life Insurance for Rs 14.5bn during 2012 in addition to 26% stake sale in life insurance business. Nippon Life Insurance, Japan's biggest life insurer, manages an AUM of over $600 billion in assets (highest in the world for any life insurer). RCAM should benefit from Nippon Lifes allocation to Indias equity opportunities. Refer to the exhibit below for a break-up of Nippon Lifes AUM. As evident, the foreign securities portfolio stands at ~$140bn of which even 1% equity allocation to India would mean ~Rs80bn (10% of RCAMs MF AUM). Exhibit 18: Nippon life insurances AUM breakup
Domestic stocks, 73.9 Loans, 106.1
Corporate bonds, 39.2 Local govt bonds, 19.3 Other securities, 4.5 National govt bonds, 178.5
Declining contribution to motor pool losses: Since the dismantling of the Motor third party loss pool, the contribution of RGEN to the pool has been on the decline. For FY2012, RGEN contributed Rs2.2bn to the motor third party loss pool while in FY2013 the share of Rs1.8bn has been up-fronted in Q2FY13 itself. This leaves incremental loss share of just Rs600-700mn to be booked in FY2014. The dramatic reduction in the contribution should boost RGENs profitability. Exhibit 20: Trend in RGENs share in motor pool losses (Rs mn)
FY2008 0.0 (500.0) (1000.0) (1500.0) (2000.0) (2500.0)
Source: Company, Centrum Research Estimates
FY2009
FY2010
FY2011
FY2012
FY2013E FY2014E
(310)
(370)
(360) (650)
(1,840) (2,160)
(1,840)
Focus on diversification: While the premium mix remains heavily skewed towards motor third party, RGEN has been consciously trying to diversify its premium flow mix. As evident in the table below, the share of Motor segment for RGEN stands at 55% compared with 48% for private players and 41% for the industry. As against this, RGEN lags the industry and other private players in the health insurance segment. With a view to balance its premium mix, RGEN is focusing on fire and engineering product segments given its big ticket and relatively less risky business profile. Exhibit 21: RGEN - Premium %YoY (June2012) Exhibit 22: Industry - Premium %YoY (June2012)
(%) 200.0 150.0 100.0 50.0 0.0 (50.0) All Others Motor OD Per Accident Motor Liability Engineering Aviation Health Motor TP Marine Cargo Marine Marine Hull Grand Total Fire
(%) 50.0 40.0 30.0 20.0 10.0 0.0 (10.0) (20.0) All Others Engineering Motor OD Liability Personal Accident Aviation Health Marine Hull Grand Total Motor TP Marine Marine Cargo Motor Fire
Operational restructuring to aid profitability: In addition to the improving dynamics for the general insurance industry, RGEN has undertaken operational restructuring to improve productivity and efficiency. For instance, RGEN has minimized the use of written cover notes for motor insurance and shifted the activity to a centralized system with a view to contain frauds and ensure a tight leash on claims etc. As evident below, the claims in motor (own damage) were unusually high at 88% by the end of 1 year (vs 50% for third party) pointing to potential fraud or malpractices in operations. Increased productivity of operations and streamlining of processes should aid improvement in profitability. Exhibit 24: Product wise trend in claims (cumulative basis)
100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 0 day Fire Engineering
Source: Company, Centrum Research
30 d Marine Health
31 d to 6 m Motor OD Miscellaneous
6 m to 1 yr Motor TP
Home Loan
LAP
CVs
Auto
Infra financing
SME
Others
Loan growth
Source: Company, Centrum Research
Mortgages
CVs
Auto
SME
Niche positioning = healthy pricing power: The commercial lending business is focused on self-employed customers, a segment better served by NBFCs rather than banks. Dissecting further, RCAP typically serves relatively low risk and high ticket customers in the self employed segment as reflected by the loan yields (~15% vs 18-20% for many NBFCs). The niche positioning has endowed RCAP with a healthy pricing power given the low interest rate sensitivity of self-employed customers. Exhibit 27: Segmental yield comparison (%)
16 14 12 10 8 6 4 2 0 Home Loan LAP Infrafinancing Auto SME CVs 13 14 13 14 15 15
Declining wholesale funding costs to boost NIMs: Due to the skewed borrowing profile towards wholesale-funded coupled with tight liquidity in recent quarters, NIMs for lending businesses have seen material contraction. The NIM has contracted from ~6% in Q1FY11 to 4% in Q1FY13. However, the benefit of easing in wholesale funding costs is beginning to flow in with Q2FY13 NIMs witnessing a 10bps uptick as cost of funds have eased gradually. We expect NIMs to improve further in FY13 and FY14 led by further easing in wholesale funding costs.
10
Yield
Source Company, Centrum Research
Cost of Funds
NIM RHS
Dec-11
Mar-12
Jun-11
Oct-11
Apr-11
Nov-11
Apr-12
Jun-12
Aug-11
May-11
May-12
Aug-12
3m
Source Company, Centrum Research
6m
12m
Strong hold on asset quality: RCAPs niche positioning (relatively low risk self employed profile of customers) along with robust underwriting processes have ensured a strong asset quality matrix. As evident in the exhibit below, %GNPA stand at a healthy 1.5% (90 day basis) at the end of Q2FY13 while the provisioning coverage has been shored up to 70% in recent quarters. The healthy asset quality matrix (relatively better than many leading banks), despite limited access to supplementary data on borrowers available to banks, speaks volumes about the robust underwriting standards and processes put in place. Given the calibrated approach towards lending since FY2012 and clear focus on secured products, we expect asset quality to remain healthy.
11
Nov-12
Jul-11
Sep-11
Feb-12
Jul-12
Sep-12
Jan-12
%GNPA
Source Company, Centrum Research
Coverage ratio
Better macro should unleash growth potential: After robust loan book expansion during FY2011 and H1FY12, RCAP has dramatically lowered its loan book expansion with % YoY growth in lower single digits for the past three quarters. The shift in growth pattern is driven by the focus on maintaining robust asset quality matrix and the endeavor to build a profitable book. In line, we believe that gradually improving macro scenario and positive sentiments should pave the way for improvement in the growth momentum for lending business. The management has already guided for a higher growth rate (~15% YoY) for FY13 and FY14. Importantly, the unlocking of capital from investment portfolio and anticipated dividend flow from subsidiaries over medium term should ensure sufficient capital flow for expansion of the loan book. Exhibit 31: Trend in loan book, % YoY
160,000 140,000 120,000 100,000 80,000 60,000 40,000 20,000 0
Loan growth
12
13
14
15
Financials (Consolidated)
Exhibit 41: Income Statement
Y/E March (Rsmn) Interest income Interest expense Net interest income Non interest income Total income Operating expenses Pre-provision op (PPOP) Investments written off Provision for NPA Provision for std debts Total provisions Profit Before Tax (PBT) Tax Net Profit (Pre minority) Minority & Associates Reported Net Profit FY11 22,320 14,640 7,680 33,040 40,720 35,590 5,130 (110) 2,200 140 2,230 2,900 570 2,330 580 2,910 FY12 28,220 22,500 5,720 38,050 43,770 36,060 7,710 1,300 1,130 90 2,520 5,190 1,900 3,290 1,290 4,580 FY13E 29,913 22,725 7,188 43,758 50,946 39,738 11,208 1,300 1,243 95 2,638 8,570 2,914 5,656 (70) 5,726 FY14E 32,306 23,180 9,127 50,320 59,447 45,774 13,673 1,300 1,367 100 2,767 10,906 3,708 7,198 (70) 7,268 FY15E 35,537 24,338 11,198 57,869 69,067 52,491 16,576 1,300 1,504 105 2,909 13,667 4,647 9,020 (70) 9,090
35 10 8 0 48 0
31 6 20 1 38 4
18 10 21 4 37 10
18 11 23 5 37 5
24 8 27 6 30 5
95 15 3 0 (13) 0
79 9 7 1 4 1
57 38 22 2 (15) (5)
36 68 81 10 (94) (2)
64 36 44 10 (59) 5
16
Appendix A
Disclaimer
Centrum Broking Limited (Centrum) is a full-service, Stock Broking Company and a member of The Stock Exchange, Mumbai (BSE) and National Stock Exchange of India Ltd. (NSE). Our holding company, Centrum Capital Ltd, is an investment banker and an underwriter of securities. As a group Centrum has Investment Banking, Advisory and other business relationships with a significant percentage of the companies covered by our Research Group. Our research professionals provide important inputs into the Group's Investment Banking and other business selection processes. Recipients of this report should assume that our Group is seeking or may seek or will seek Investment Banking, advisory, project finance or other businesses and may receive commission, brokerage, fees or other compensation from the company or companies that are the subject of this material/report. Our Company and Group companies and their officers, directors and employees, including the analysts and others involved in the preparation or issuance of this material and their dependants, may on the date of this report or from, time to time have "long" or "short" positions in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. Centrum or its affiliates do not own 1% or more in the equity of this company Our sales people, dealers, traders and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. We may have earlier issued or may issue in future reports on the companies covered herein with recommendations/ information inconsistent or different those made in this report. In reviewing this document, you should be aware that any or all of the foregoing, among other things, may give rise to or potential conflicts of interest. We and our Group may rely on information barriers, such as "Chinese Walls" to control the flow of information contained in one or more areas within us, or other areas, units, groups or affiliates of Centrum. Centrum or its affiliates do not make a market in the security of the company for which this report or any report was written. Further, Centrum or its affiliates did not make a market in the subject companys securities at the time that the research report was published. This report is for information purposes only and this document/material should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this document nor anything contained herein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. This document does not solicit any action based on the material contained herein. It is for the general information of the clients of Centrum. Though disseminated to clients simultaneously, not all clients may receive this report at the same time. Centrum will not treat recipients as clients by virtue of their receiving this report. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Similarly, this document does not have regard to the specific investment objectives, financial situation/circumstances and the particular needs of any specific person who may receive this document. The securities discussed in this report may not be suitable for all investors. The securities described herein may not be eligible for sale in all jurisdictions or to all categories of investors. The countries in which the companies mentioned in this report are organized may have restrictions on investments, voting rights or dealings in securities by nationals of other countries. The appropriateness of a particular investment or strategy will depend on an investor's individual circumstances and objectives. Persons who may receive this document should consider and independently evaluate whether it is suitable for his/ her/their particular circumstances and, if necessary, seek professional/financial advice. Any such person shall be responsible for conducting his/her/their own investigation and analysis of the information contained or referred to in this document and of evaluating the merits and risks involved in the securities forming the subject matter of this document. The projections and forecasts described in this report were based upon a number of estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections and forecasts were based will not materialize or will vary significantly from actual results, and such variances will likely increase over time. All projections and forecasts described in this report have been prepared solely by the authors of this report independently of the Company. These projections and forecasts were not prepared with a view toward compliance with published guidelines or generally accented accounting principles. No independent accountants have expressed an opinion or any other form of assurance on these projections or forecasts. You should not regard the inclusion of the projections and forecasts described herein as a representation or warranty by or on behalf of the Company, Centrum, the authors of this report or any other person that these projections or forecasts or their underlying assumptions will be achieved. For these reasons, you should only consider the projections and forecasts described in this report after carefully evaluating all of the information in this report, including the assumptions underlying such projections and forecasts. The price and value of the investments referred to in this document/material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance. Future returns are not guaranteed and a loss of original capital may occur. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. Centrum does not provide tax advice to its clients, and all investors are strongly advised to consult regarding any potential investment. Centrum and its affiliates accept no liabilities for any loss or damage of any kind arising out of the use of this report. Foreign currencies denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of or income derived from the investment. In addition, investors in securities such as ADRs, the value of which are influenced by foreign currencies effectively assume currency risk. Certain transactions including those involving futures, options, and other derivatives as well as non-investment-grade securities give rise to substantial risk and are not suitable for all investors. Please ensure that you have read and understood the current risk disclosure documents before entering into any derivative transactions. This report/document has been prepared by Centrum, based upon information available to the public and sources, believed to be reliable. No representation or warranty, express or implied is made that it is accurate or complete. Centrum has reviewed the report and, in so far as it includes current or historical information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The opinions expressed in this document/material are subject to change without notice and have no obligation to tell you when opinions or information in this report change. This report or recommendations or information contained herein do/does not constitute or purport to constitute investment advice in publicly accessible media and should not be reproduced, transmitted or published by the recipient. The report is for the use and consumption of the recipient only. This publication may not be distributed to the public used by the public media without the express written consent of Centrum. This report or any portion hereof may not be printed, sold or distributed without the written consent of Centrum. This report has not been prepared by Centrum Securities LLC. However, Centrum Securities LLC has reviewed the report and, in so far as it includes current or historical information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The distribution of this document in other jurisdictions may be restricted by law, and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Neither Centrum nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. This document does not constitute an offer or invitation to subscribe for or purchase or deal in any securities and neither this document nor anything contained herein shall form the basis of any contract or commitment whatsoever. This document is strictly confidential and is being furnished to you solely for your information, may not be distributed to the press or other media and may not be reproduced or redistributed to any other person. The distribution of this report in other jurisdictions may be restricted by law and persons into whose possession this report comes should inform themselves about, and observe any such restrictions. By accepting this report, you agree to be bound by the fore going limitations. No representation is made that this report is accurate or complete. The opinions and projections expressed herein are entirely those of the author and are given as part of the normal research activity of Centrum Broking and are given as of this date and are subject to change without notice. Any opinion estimate or projection herein constitutes a view as of the date of this report and there can be no assurance that future results or events will be consistent with any such opinions, estimate or projection.
17
This document has not been prepared by or in conjunction with or on behalf of or at the instigation of, or by arrangement with the company or any of its directors or any other person. Information in this document must not be relied upon as having been authorized or approved by the company or its directors or any other person. Any opinions and projections contained herein are entirely those of the authors. None of the company or its directors or any other person accepts any liability whatsoever for any loss arising from any use of this document or its contents or otherwise arising in connection therewith. Centrum and its affiliates have not managed or co-managed a public offering for the subject company in the preceding twelve months. Centrum and affiliates have not received compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for service in respect of public offerings, corporate finance, debt restructuring, investment banking or other advisory services in a merger/acquisition or some other sort of specific transaction. As per the declarations given by them, Mr. Bhavesh Kanani, research analyst and and/or any of his family members do not serve as an officer, director or any way connected to the company/companies mentioned in this report. Further, as declared by him, he has not received any compensation from the above companies in the preceding twelve months. Our entire research professionals are our employees and are paid a salary. They do not have any other material conflict of interest of the research analyst or member of which the research analyst knows of has reason to know at the time of publication of the research report or at the time of the public appearance. While we would endeavour to update the information herein on a reasonable basis, Centrum, its associated companies, their directors and employees are under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent Centrum from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or Centrum policies, in circumstances where Centrum is acting in an advisory capacity to this company, or any certain other circumstances Key to Centrum Investment Rankings: Stock to Sector Sector to Market Outperform Outperform Neutral Underperform Outperform Neutral Neutral Underperform Outperform Underperform Neutral Underperform Accumulate: Add on decline; Reduce: Sell on rise Stock to Sector This is the relative rating of the stock to the sector and reflects its relative attractiveness vis--vis other coverage stocks in the sector. Sector to Market This is the relative rating of the sector vis--vis the other sectors in the coverage space. This is derived based on the conviction of the analyst on a sector and macro view outlined in market strategy. Stock to Market The final rating on the stock is obtained as a combination of the stock to sector and sector to market view as outlined in the table above. Stock to Market Buy Buy Accumulate Neutral Neutral Neutral Reduce Sell Sell
18
Member (NSE, BSE, MCX-SX), Depository Participant (CDSL) and SEBI registered Portfolio Manager Registration Nos. CAPITAL MARKET SEBI REGN. NO.: BSE: INB011454239, NSE: INB231454233 DERIVATIVES SEBI REGN. NO.: NSE: INF231454233 (TRADING & SELF CLEARING MEMBER) CDSL DP ID: 12200. SEBI REGISTRATION NO.: IN-DP-CDSL-661-2012 PMS REGISTRATION NO.: INP000004383 MCX SX (Currency Derivative segment) REGN. NO.: INE261454236 Website: www.centrum.co.in Investor Grievance Email ID: [email protected] Compliance Officer Details: Mr. Praveen Malik; Tel: (022) 4215 9703; Email ID: [email protected]
19